Q2 2024 EPS Estimates for Henry Schein, Inc. Reduced by Analyst (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Barrington Research reduced their Q2 2024 EPS estimates for shares of Henry Schein in a research note issued to investors on Wednesday, May 8th. Barrington Research analyst M. Petusky now expects that the company will earn $1.27 per share for the quarter, down from their previous forecast of $1.30. Barrington Research has a “Outperform” rating and a $92.00 price target on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Barrington Research also issued estimates for Henry Schein’s Q3 2024 earnings at $1.31 EPS, Q4 2024 earnings at $1.42 EPS, FY2024 earnings at $5.10 EPS, Q1 2025 earnings at $1.14 EPS, Q2 2025 earnings at $1.34 EPS, Q3 2025 earnings at $1.39 EPS, Q4 2025 earnings at $1.59 EPS and FY2026 earnings at $6.00 EPS.

A number of other research firms also recently weighed in on HSIC. SVB Leerink assumed coverage on shares of Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 target price for the company. Evercore ISI lifted their target price on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. UBS Group cut their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday. Jefferies Financial Group lifted their price objective on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $81.73.

Henry Schein Trading Up 2.2 %

NASDAQ HSIC opened at $72.76 on Thursday. Henry Schein has a 12 month low of $60.01 and a 12 month high of $82.63. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $9.35 billion, a PE ratio of 23.10, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87. The business’s 50-day moving average price is $73.01 and its two-hundred day moving average price is $72.34.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.21 earnings per share.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. State Board of Administration of Florida Retirement System grew its holdings in Henry Schein by 7.0% during the first quarter. State Board of Administration of Florida Retirement System now owns 185,054 shares of the company’s stock valued at $15,089,000 after purchasing an additional 12,087 shares during the period. Sei Investments Co. grew its stake in shares of Henry Schein by 5.9% during the 1st quarter. Sei Investments Co. now owns 389,789 shares of the company’s stock worth $29,437,000 after acquiring an additional 21,740 shares during the period. Foyston Gordon & Payne Inc raised its stake in Henry Schein by 99.5% in the 1st quarter. Foyston Gordon & Payne Inc now owns 144,102 shares of the company’s stock valued at $10,883,000 after acquiring an additional 71,870 shares during the period. Forsta AP Fonden lifted its holdings in Henry Schein by 8.9% during the first quarter. Forsta AP Fonden now owns 24,500 shares of the company’s stock valued at $1,850,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Illinois Municipal Retirement Fund boosted its position in Henry Schein by 0.6% during the first quarter. Illinois Municipal Retirement Fund now owns 95,899 shares of the company’s stock worth $7,242,000 after purchasing an additional 575 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insiders Place Their Bets

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.